ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Investigation of the effects of tigecycline, a semi-synthetic derivative of minocycline, on chondrocyte cultures

Yasin Emre Kaya, Numan Karaarslan, Ibrahim Yilmaz, Duygu Yasar Sirin, Onur Yaman, Hanefi Ozbek, Ozkan Ates.



Abstract
Download PDF Cited by 1 ArticlesPost

Aim: Although antibiotics are generally well-tolerated, they may have cytotoxic effects. The present randomized, double-blind, in vitro study aimed to investigate the effects of tigecycline on cartilage tissue cells and the extracellular matrix.
Material and Methods: Cartilage tissues of patients (n = 8) were used for the preparation of primary cell cultures. Tigecycline-treated cell cultures served as the study group. Non-treated cell cultures served as the control group. Analyses were performed at 0, 24, 48, and 72 h in both groups. The results obtained were statistically evaluated. The alpha significance value was determined to be 0.05.
Results: Proliferation remained unchanged in the tigecycline-treated cell cultures. The gene expressions of the markers involved in anabolic pathways increased in the tigecycline-treated cell cultures. The results obtained were statistically significant (P < 0.05).
Conclusion: Although tigecycline had no toxic effect on the chondrocyte cell cultures and caused no damage to the extracellular matrix, the present study was performed in an in vitro environment.

Key words: Chondroadherin gene; Cartilage oligomeric protein; Interleukin-1beta; Matrix metalloproteinase; Primary chondrocyte culture; Tigecycline







Bibliomed Article Statistics

30
23
27
17
34
43
30
26
17
23
15
15
R
E
A
D
S

17

19

17

10

22

10

13

12

9

6

9

8
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.